Kindly His ‘at home semen analysis kit
Hormonal wellness can be intimidating, as it touches the most intimate parts of our lives. Good health wants to make it accessible to more people, with a combination of home diagnostic tests (including semen analysis and polycystic ovary syndrome testing), teleconsultation and supplements.
The Bangalore-based startup, which has ambitions to expand into the global market, today announced it has raised US$3.25 million from investors including Y Combinator, Olive Tree, Soma , Goodwater and Gaingels.
Kindly Health has two product lines: KindlyHis and KindlyHers. KindlyHers will launch a PCOS prediction test that can help women diagnose and manage PCOS. It also sells routine lab work for PCOS configurations and STD diagnoses. KindlyHis sperm tests allow users to perform the test at home and then send it to a testing center for diagnosis.
Kindly Health was founded in 2020 by Nilay Mehrotra, its CEO, and was formerly known as Janani.life. Mehrotra told TechCrunch that before joining Y Combinator’s winter 2022 cohort, Kindly Health was focused on fertility, specifically building a B2B tool for IVF clinics to help them choose the right embryos. .
“But as we started to better understand our market and our customers, we realized the real problem was much bigger and we needed to focus on lifestyle disorders,” he said. “We recognize that at-home semen testing and diagnostics has a much larger use case than just fertility, and we don’t want to limit ourselves to that.”
Since launching a month ago, Mehrotra says revenue growth is trending at 30% month-over-month, and the company expects to hit $1 million in revenue by the end of the year.
Mehrotra says the market opportunity in India for lifestyle, sexual and hormonal health disorders is $8 billion, based on the startup’s findings that 130 million people in India spend approx. $60 for sexual and effective wellness products.
In the future, Kindly Health will also focus on more healthcare categories and expand the product portfolio to include eczema, psoriasis and gut health. Its goal is to get 130 million users and it plans to launch an app within the next few months.
